Page last updated: 2024-09-03

lestaurtinib and Adenoma, Sweat Gland

lestaurtinib has been researched along with Adenoma, Sweat Gland in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashworth, A; Burn, J; Clewes, O; Elliott, R; Langtry, J; Lord, CJ; Mackay, A; Rajan, N; Reis-Filho, JS; Sieber-Blum, M1

Other Studies

1 other study(ies) available for lestaurtinib and Adenoma, Sweat Gland

ArticleYear
Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.
    Oncogene, 2011, Oct-13, Volume: 30, Issue:41

    Topics: Adenoma, Sweat Gland; Carbazoles; Carcinoma, Adenoid Cystic; Cluster Analysis; Comparative Genomic Hybridization; Deubiquitinating Enzyme CYLD; Furans; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Immunohistochemistry; Mutation; Neoplasms; Neoplasms, Basal Cell; Oligonucleotide Array Sequence Analysis; Primary Cell Culture; Protein Kinases; Receptor, trkB; Receptor, trkC; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Sweat Gland Neoplasms; Tissue Array Analysis; Tumor Cells, Cultured; Tumor Suppressor Proteins

2011